Molecular Spectroscopy Market Size, Share & Industry Analysis, By Product Type (Instruments, Accessories & Consumables, and Software), By Technology (Infrared (IR) Spectroscopy, UV-visible Spectroscopy, Raman Spectroscopy, Nuclear Magnetic Resonance (NMR) Spectroscopy, and Others), By End-user (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Clinical & Diagnostic Laboratories, and Others), and Regional Forecast, 2026-2034

The global molecular spectroscopy market size was valued at USD 4.72 billion in 2025. The market is projected to grow from USD 5.03 billion in 2025 to USD 8.57 billion by 2034, exhibiting a CAGR of 6.9% during the forecast period.

Molecular spectroscopy is an analytical technique used to identify, quantify, and characterize materials using electromagnetic radiation in various industries, including pharmaceuticals and biotechnology, as well as academic and research institutes, for process monitoring and regulatory documentation. The market growth is attributed to the increasing demand for spectroscopy instruments and consumables, driven by the growing need for QA/QC automation and R&D workflows.

Furthermore, the market is led by major players, including Bruker, Thermo Fisher Scientific Inc., and Agilent Technologies Inc. These players' portfolios of advanced instruments, incorporating new technologies and a strong global reach, contribute to their market share.

MOLECULAR SPECTROSCOPY MARKET TRENDS

AI-enabled Spectral Analytics and Multimodal Workflows to Emerge as a Key Market Trend

Currently, there has been an increasing integration of spectroscopy hardware with stronger software, AI/chemometrics, and imaging. Companies are integrating AI-powered evaluation and multimodal imaging into their IR imaging microscope workflows.

• For instance, Bruker launched LUMOS II ILIM, a quantum cascade laser (QCL)-based infrared imaging microscope, highlighting that software is becoming a differentiator rather than an add-on.

Moreover, key players are expanding their portfolio with Raman spectroscopy instruments and software that enable faster measurements, improved sensitivity, and greater sampling flexibility, thereby improving overall performance.

Download Free sample to learn more about this report.

MARKET DYNAMICS

MARKET DRIVERS

Standard Regulations for Quality Assurance (QA)/Quality Control (QC) and Process Analytical Technology (PAT) to Drive the Market Growth

The increasing R&D initiatives by pharmaceutical & biotechnology companies, along with standard regulations for manufacturing, are driving the demand for molecular spectroscopy in rapid identity testing, impurity checks, release decisions, and process analytical technology (PAT), to reduce cycle time and avoid destructive testing.

In response, key players are launching new instruments to support their operations. Additionally, the growing production of biologics and complex formulations is driving the need for rapid and standardized solutions such as spectroscopy systems. This is projected to drive the global molecular spectroscopy market growth during the forecast period.

• For instance, in April 2023, Agilent Technologies Inc., launched the Cary 3500 Flexible UV-Vis system with explicit positioning for pharmaceutical & biopharma and regulated environments.

MARKET RESTRAINTS

High Cost and Skills Gap to Restrict Market Growth

Despite the strong use of molecular spectroscopy instruments and consumables, their adoption is hindered by key factors, including high capital costs, ongoing calibration/validation burdens, and limited availability of experts, especially for Raman/NMR and imaging workflows.

• For instance, in December 2025, LabX mentioned that new spectroscopy systems generally cost between USD 15,000 and USD 200,000.

The higher costs of service, compliance, training, and method development are particularly delaying upgrades or limiting deployment beyond core QC for many smaller laboratories, which is expected to hinder market growth.

MARKET OPPORTUNITIES

Shift toward High-throughput Spectroscopy to Offer Lucrative Growth Opportunities

In recent years, there has been a growing shift from single-point measurements to high-throughput screening and chemical imaging, particularly for tablets, tissues, microplastics, and heterogeneous materials.

As a result, major players are capitalizing on these opportunities through new launches, such as a high-throughput Raman screening instrument and molecular fingerprinting tools.

• For instance, in March 2025, HORIBA announced the launch of three new analytical instruments, including the Veloci A-TEEM BioPharma Analyzer for molecular fingerprinting in biopharma applications such as vaccine development and protein analysis, the PoliSpectra Rapid Raman Plate Reader for high-throughput 96-well screening in under a minute, and the SignatureSPM AFM platform integrated with Raman for multimodal material characterization.

MARKET CHALLENGES

Standardization across Instruments, Samples, and Methods to Challenge Market Growth

In recent years, reproducibility and transferability have posed a persistent challenge in sample preparation, instrument configurations, and chemometric models, thereby complicating the transfer of methods across sites and suppliers.

Although the instruments are designed for productivity, laboratories worldwide still require robust validation and consistent reference materials, which are challenging their adoption and market growth.

Segmentation Analysis

By Product Type

Increasing New Purchase Rate of Instruments to Drive Segmental Growth

Based on segmentation by product type, the market is classified as instruments, accessories & consumables, and software.

To know how our report can help streamline your business, Speak to Analyst

The instrument segment accounted for the major market share of molecular spectroscopy in 2025. The growth is primarily driven by an increasing new purchase rate of high-priced instruments and multi-year replacement cycles, which are fueled by performance upgrades, compliance needs, and expanding applications.

In addition, the accessories & consumables segment is projected to grow at a CAGR of 7.3% during the forecast period.

By Technology

New Product Launches to Drive the Infrared (IR) Spectroscopy Segment’s Growth

Based on technology, the market is segmented into infrared (IR) spectroscopy, UV-visible spectroscopy, Raman spectroscopy, nuclear magnetic resonance (NMR) spectroscopy, and others.

The infrared (IR) spectroscopy segment held the largest market share in 2025. The segment’s growth is attributed to new product innovations such as relatively fast and cost-effective IR spectroscopy instruments. These instruments are in an increasing demand in the fields of chemicals, pharmaceutical solids, and forensics.  Furthermore, the segment is expected to hold a share of 31.5% in 2026.

• In March 2022, Shimadzu Corporation launched the IRXross FTIR spectrophotometer, featuring top-class sensitivity with a signal-to-noise (S/N) ratio of 55,000:1, twice that of its predecessor, the IRAffinity-1S. The new device also features enhanced resolution and high-speed analysis for pharmaceutical and chemical applications.

In addition, the nuclear magnetic resonance (NMR) spectroscopy segment is projected to grow at a CAGR of 6.9% during the forecast period.

By End-user

Increasing QA/QC and R&D Requirements of Pharmaceutical & Biotechnology Companies to Propel the Segment Growth

In terms of end-user, the market is categorized into pharmaceutical & biotechnology companies, academic & research institutes, clinical & diagnostic laboratories, and others.

In 2025, the pharmaceutical & biotechnology companies segment dominated the market in terms of end-users. The segment’s growth is attributed to the increasing number of pharmaceutical & biotechnology companies that require spectroscopy instruments for quality control/quality assurance, drug discovery and development, as well as research initiatives worldwide. Furthermore, the segment is set to hold 38.4% share in 2026.

In addition, the academic & research institutes segment is projected to grow at a CAGR of 7.1% during the forecast period.

Molecular Spectroscopy Market Regional Outlook

Based on geography, the market is classified into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America

To get more information on the regional analysis of this market, Download Free sample

North America accounted for the largest market share in 2024 with a value of USD 1.60 billion and continued its dominance in 2025 with a value to USD 1.70 billion. The regional growth is attributed to the region’s strong pharmaceutical & biotechnology base, high R&D spending, and early adoption of advanced analytical technologies. In 2026, the U.S. market is projected to reach USD 1.80 billion.

• For instance, in August 2025, Cross River Therapy mentioned that there were more than 5,000 pharmaceutical companies in the U.S.

U.S. Molecular Spectroscopy Market

In 2026, the U.S. market is expected to reach a value of USD 1.63 billion, accounting for 32.4% of the global market revenue.

Europe

Europe is projected to register a growth rate of 6.1% in the coming years, the second-highest worldwide, reaching a market size of USD 1.49 billion by 2026. The growth is primarily driven by strong academic and industry collaboration, as well as stringent regulatory frameworks, which are expected to increase the utilization of spectroscopy instruments and consumables.

U.K. Molecular Spectroscopy Market

The U.K. market is expected to reach USD 0.26 billion by 2026, accounting for approximately 5.1% of the global market revenue.

Germany Molecular Spectroscopy Market

The Germany market is projected to reach about USD 0.41 billion by 2026, representing roughly 8.1% of the global market.

Asia Pacific

In 2026, the Asia Pacific market is forecasted to reach USD 1.47 billion, ranking as the third-largest region in the market, with India and China expected to contribute USD 0.15 billion and USD 0.65 billion, respectively.

Japan Molecular Spectroscopy Market

Japan is estimated to reach USD 0.38 billion in 2026, holding approximately 7.6% of the global market.

China Molecular Spectroscopy Market

China is projected to reach USD 0.65 billion by 2026, representing 12.9% of the global market.

India Molecular Spectroscopy Market

India’s market is anticipated to account for USD 0.15 billion by 2026, holding around 3.0% of the global industry.

Latin America and Middle East & Africa

Latin America and the Middle East & Africa regions are expected to experience moderate growth in this market over the forecast period. Latin America is set to reach USD 0.16 billion by 2026, driven by an increasing demand for routine FTIR and UV-Vis systems in the region. Meanwhile, the GCC in the Middle East & Africa market is predicted to reach a value of USD 0.06 billion by 2026.

COMPETITIVE LANDSCAPE

Key Industry Players

Wide Range of Innovative Product Offerings to Strengthen the Market Position of Key Players

In 2025, Bruker, Thermo Fisher Scientific Inc., and Agilent Technologies Inc. accounted for the highest global molecular spectroscopy market share. Their dominance is attributed to a portfolio of high-end spectroscopy technologies, particularly Raman, NMR, and advanced IR imaging systems, which these companies offer.

Other major companies, including HORIBA and Shimadzu Corporation, among others, are expected to hold a significant share of the market due to their strong footprint in pharmaceutical research, life sciences, materials science, and academic institutions.

LIST OF KEY MOLECULAR SPECTROSCOPY COMPANIES PROFILED

• Thermo Fisher Scientific Inc. (U.S.)
• Agilent Technologies, Inc. (U.S.)
• Bruker (U.S.)
• Shimadzu Corporation (Japan)
• HORIBA (Japan)
• Revvity (U.S.)
• Metrohm AG (Switzerland)
• JEOL Ltd (Japan)
• Renishaw plc. (U.S.)
• Oxford Instruments (U.K.)

KEY INDUSTRY DEVELOPMENTS

• March 2025: BrightSpec launched the world's first commercial molecular rotational resonance (MRR) instrument at Pittcon 2025. The solution features the sisoMRR for quantifying volatile/chiral compounds, pectraMRR for chemical structure identification, and compact nanoMRR for education and analysis.
• March 2025: HORIBA launched the Veloci BioPharma Analyzer, featuring A-TEEM spectroscopy for rapid, label-free molecular fingerprinting in biopharma and pharma applications.
• April 2024: Metrohm AG introduced the 2060 XRF Process Analyzer, its first EDXRF spectrometer for reliable, non-destructive online analysis of elements ranging from magnesium to uranium in liquid samples.
• March 2024: Thermo Fisher Scientific Inc. launched the Nicolet Apex FTIR Spectrometer, accompanied by the intuitive OMNIC Paradigm software for automated workflows in materials, pharmaceutical, and environmental analysis.
• April 2023: Agilent Technologies, Inc. launched the Cary 3500 Flexible UV-Vis System. The solution is a double-beam spectrophotometer featuring advanced photometric performance for analyzing diverse liquid and solid samples in pharmaceutical and biopharmaceutical environments.

REPORT COVERAGE

The global molecular spectroscopy market report delivers a thorough analysis of the market across all segments, covering key drivers, trends, opportunities, challenges, and restraints. It provides essential insights on technological advancements, new product launches and approvals, significant industry developments, market share breakdowns, regulations for QA/QC, and the profiles of leading companies.

To gain extensive insights into the market, Download for Customization

Report Scope & Segmentation